Markets
API & Formulation Products
Kleem Pharmaceuticals is a virtual pharma service provider supplying APIs and formulations to the export market. We operate through CMO and CDMO business models. Our headquarters is in Hyderabad, Telangana, India, with marketing branches in Dubai and the United Kingdom. We specialize in exporting bulk drugs, API intermediates, and formulations.
Our business methodology focuses on achieving futuristic backward-integration synergy. We ensure 100% fulfilment of production commitments for APIs and extended product lines. We have a presence in more than 30 countries, including South East Asia, Asia Pacific, Africa, North America, tNA, Latin America, CIS and the MENA region.
To redefine pharmaceutical accessibility by providing world-class products and integrated virtual pharma solutions to global markets with trust, innovation, and compliance at the core.
To seamlessly bridge manufacturers and global markets through reliable supply chains, strong regulatory support, and future-ready pharmaceutical capabilities.
At Kleem Pharmaceuticals, we are committed to delivering reliable, high-quality pharmaceutical solutions that meet global standards.
We follow strict global standards to ensure every product meets the highest level of safety and efficacy.
From development to delivery, our team manages every step with precision and professionalism.
State-of-the-art facilities and technology enable us to produce consistent, reliable, and scalable outcomes.
Our strong regulatory knowledge ensures smooth approvals and compliant documentation for global markets.
We prioritize transparency, timely support, and long-term relationships with every partner.
We constantly evolve to deliver modern, effective, and future-ready pharmaceutical solutions.
At Kleem Pharmaceuticals, our approach is rooted in precision, partnership, and performance. We combine strong scientific understanding with global market expertise to deliver end-to-end pharmaceutical solutions that are reliable, compliant, and future-ready.
We operate through a collaborative virtual-pharma model, integrating the strengths of leading CMO and CDMO partners. This enables us to offer flexible manufacturing, rapid scalability, and consistent product quality across diverse markets.
Whatsapp Now